Abiopharma

🔍 Lammers Hendrik Rene (Executive)

Company: ESTEE LAUDER COMPANIES INC (EL)

Report Date: 2026-08-27

Detailed Transactions and Holdings:

• Acquired 7,909 shares of Restricted Stock Units (Share Payout) (Derivative)
  Date: 2026-08-27 | Code: A | Expires: 2029-11-01 | Exercise: 2027-11-01 | equity_swap_involved: 0 | shares_owned_after: 7,909.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3
• Acquired 9,416 shares of Restricted Stock Units (Share Payout) (Derivative)
  Date: 2026-08-27 | Code: A | Expires: 2029-11-01 | Exercise: 2027-11-01 | equity_swap_involved: 0 | shares_owned_after: 9,416.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F4
• Acquired 28,820 shares of Stock Option (Right to Buy) at $106.21 per share (Derivative)
  Date: 2026-08-27 | Code: A | Expires: 2036-08-27 | Exercise: 2027-11-01 | equity_swap_involved: 0 | shares_owned_after: 28,820.00 | transaction_form_type: 4 | Footnotes: F2, F5

Footnotes:

• F1: Restricted Stock Units ("RSUs") vest and are paid out in shares of Class A Common Stock on a one-to-one basis on the applicable vesting date. RSUs generally vest in three approximately equal installments unless otherwise indicated. Upon payout, shares are withheld to cover statutory tax obligations. RSUs are accompanied by dividend equivalent rights payable in cash at the time of the payout of the related shares.
• F2: Not applicable.
• F3: Annual RSUs granted August 27, 2026. Assuming continued employment, these RSUs will vest and be paid out as follows: 2,636 on November 1, 2027; 2,636 on November 1, 2028; and 2,637 on November 1, 2029.
• F4: Non-annual RSUs granted August 27, 2026. Assuming continued employment, these RSUs will vest and be paid out as follows: 3,138 on November 1, 2027; 3,139 on November 1, 2028; and 3,139 on November 1, 2029.
• F5: Stock options granted pursuant to The Estee Lauder Companies Inc. Amended and Restated Fiscal 2002 Share Incentive Plan in respect of: 9,606 shares exercisable from and after November 1, 2027; 9,607 shares exercisable from and after November 1, 2028; and 9,607 shares exercisable from and after November 1, 2029.